Related Experiment Video

Updated: May 17, 2026

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

Using cellular mechanisms to develop effective combinations of photodynamic therapy and targeted therapies

Tayyaba Hasan1

  • 1Wellman Center for Photomedicine, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA. thasan@partners.org

Journal of the National Comprehensive Cancer Network : JNCCN
|October 12, 2012
PubMed

Insights

Photodynamic therapy (PDT) offers a novel cancer treatment. This study explores combining PDT with targeted therapies by either guiding treatment by the molecular response after PDT or preconditioning cells before PDT.

Area of Science:

  • Biochemistry
  • Photomedicine
  • Oncology

Background:

  • The synergy between laboratory research and clinical application is crucial in photomedicine.
  • Cancer treatment resistance necessitates exploring alternative therapeutic strategies like photodynamic therapy (PDT).
  • PDT demonstrates potential in overcoming chemoresistance and synergizing with existing cancer treatments.

Purpose of the Study:

  • To investigate two novel approaches for enhancing the efficacy of photodynamic therapy (PDT) when combined with targeted therapies.
  • To explore strategies for maximizing the photodynamic effect in cancer treatment.

Main Methods:

  • Investigating the use of post-PDT molecular responses to inform the selection of targeted agents.
  • Examining the preconditioning of cancer cells to modulate nuclear molecular targets prior to PDT administration.

Main Results:

  • The study presents two distinct biochemical strategies to optimize PDT outcomes.
  • These strategies aim to improve cancer cell response to combined therapies.

Conclusions:

  • Combining PDT with targeted therapies holds significant promise for cancer treatment.
  • Tailoring targeted agent selection based on PDT response or preconditioning cells offers innovative avenues for maximizing therapeutic effects.

More Related Videos

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology13:17

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

Published on: September 29, 2023

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers09:45

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.